SO TENN REG MED CTR OF PULASKI — History
CCN 440020 | 3-year financial timeline | COVID resilience: 79/100
🛡️ Public data only — no PHI permitted on this instance.
$45M
Latest Revenue (FY2022)
+9.1%
Revenue CAGR (3yr)
6.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $37M | $42M | $45M | +6.9% | +9.1% |
| Operating Expenses | $39M | $40M | $42M | +4.0% | +3.6% |
| Operating Margin | -3.7% | 3.9% | 6.5% | +66.1% | +0.0% |
| Net Income | $-1M | $2M | $3M | +77.6% | +0.0% |
| Licensed Beds | 81 | 81 | 81 | +0.0% | +0.0% |
| Total Patient Days | 4,849 | 6,827 | 7,141 | +4.6% | +21.4% |
| Medicare Day % | 39% | 26% | 21% | -17.8% | -26.8% |
| Medicaid Day % | 21% | 20% | 24% | +20.9% | +8.9% |
COVID Impact & Recovery
Resilience Score: 79/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +19.1% ($37M → $45M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.1%
This Hospital
+7.6%
State Avg
Latest Margin
6.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $48M | 11.6% |
| FY2024 (proj) | $52M | 16.7% |
| FY2025 (proj) | $55M | 21.8% |